Biomarkers and methods of treating PD-1 and PD-L1 related conditions
US11299544B2 · kind B2 · utility
0Cited by
9References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2015 |
| Grant date | Apr 12, 2022 |
| Priority date | — |
| Expiry date | Feb 9, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.